Your search returned 3 results.

Results
	1.	Integrated safety in tocilizumab clinical trials. [electronic resource] by Schiff, Michael H Kremer, Joel M Jahreis, Angelika Vernon, Emma Isaacs, John D van Vollenhoven, Ronald F Producer: 20121213 In: Arthritis research & therapy vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results. [electronic resource] by Fleischmann, Roy M Halland, Anne-Marie Brzosko, Marek Burgos-Vargas, Ruben Mela, Christopher Vernon, Emma Kremer, Joel M Producer: 20130801 In: The Journal of rheumatology vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year. [electronic resource] by Kremer, Joel M Blanco, Ricardo Brzosko, Marek Burgos-Vargas, Ruben Halland, Anne-Marie Vernon, Emma Ambs, Petra Fleischmann, Roy Producer: 20130124 In: Arthritis and rheumatism vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)